Thomas D. Carey
CIK: 0001574633
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)4 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
LAB
STANDARD BIOTOOLS INC.
Director
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 18, 2026LAB
STANDARD BIOTOOLS INC.
Award(A)Direct99.1K shares- - Feb 26, 2026LAB
STANDARD BIOTOOLS INC.
Award(A)Direct51.3K shares at avg. $1.17$60K - Jun 20, 2025LAB
STANDARD BIOTOOLS INC.
Award(A)Direct94.6K shares- - Feb 28, 2025LAB
STANDARD BIOTOOLS INC.
Award(A)Direct56.3K shares at avg. $1.06$60K
1-4 of 4 transactions
About Carey Thomas D.
Carey Thomas D. (SEC CIK 0001574633) files insider reports with the SEC as Director of STANDARD BIOTOOLS INC. (LAB).
Signal8 holds 4 ownership filings by Carey Thomas D., all Form 4s, filed between Mar 4, 2025 and Jun 23, 2026. Those filings report 4 transactions, from Feb 28, 2025 to Jun 18, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Carey Thomas D.'s filings is in BOSTON, MA.
Recent filings by Carey Thomas D.
Other insiders filing for STANDARD BIOTOOLS INC. (LAB)
- Mackay Sean, SVP & Chief Business Officer
- Kim Hanjoon Alex, Chief Financial Officer
- Egholm Michael, President & CEO
- Witney Frank, Director
- Casdin Eli, Director
- Cox Troy, Director